![美股異動:蘋果盤前漲0.7% 年內漲幅超32% 終止“先買後付”服務](https://i-invdn-com.investing.com/news/LYNXMPEA7306L_S.jpg)
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
泛靈頓健康的投資目標為達致長期資本增長。投資經理一直將泛靈頓健康的總資產最少三分之二投資於由 世界各地從事保健及醫療服務和產品的公司所發行的股票或股票相關金融工具以達致泛靈頓健康的目標。 該基金會投資於藥物生產商、生物科技公司、醫療器材和設備製造商、保健產品分銷商、保健供應商和經 理及其他保健服務公司。
名稱 | 主旨 | 成立於 | 直至 |
---|---|---|---|
Stephen Kelly | Portfolio Manager | 2021 | now |
自傳 | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
Peter Hughes | Portfolio Manager | 2021 | now |
自傳 | Peter is a Portfolio Manager in our Framlington Equities expertise and has specialised in bi-otech and longevity within its global strategies since joining the firm in 2015. Prior to AXA IM, Peter worked at Architas in roles covering investment research and relationship man-agement. Peter completed a PhD in biochemistry at University College London, working on a drug development project in a multidisciplinary research group collaborating with GSK. He has a master's degree in chemistry from the University of Surrey and holds the Investment Man-agement Certificate. He is also an ambassador for the Royal Marsden Cancer Charity. | ||
Linden Thomson | - | 2015 | 2021 |
Dani Saurymper | - | 2015 | 2021 |
自傳 | Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare. | ||
Gemma Game | - | 2009 | 2015 |
Deane Donnigan | clinical Specialist | 2007 | 2008 |
自傳 | Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen. |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核